Birgit Luber

3.6k total citations
58 papers, 2.9k citations indexed

About

Birgit Luber is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Birgit Luber has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Birgit Luber's work include Wnt/β-catenin signaling in development and cancer (17 papers), Cancer-related gene regulation (14 papers) and Gastric Cancer Management and Outcomes (13 papers). Birgit Luber is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (17 papers), Cancer-related gene regulation (14 papers) and Gastric Cancer Management and Outcomes (13 papers). Birgit Luber collaborates with scholars based in Germany, United States and Switzerland. Birgit Luber's co-authors include Heinz Höfler, Karl‐Friedrich Becker, Raymonde Busch, Ingrid Becker, P. H. Hofschneider, Ulrich M. Lauer, Alexander S. Kekulé, Erika Rosivatz, Katja Specht and Peter Hutzler and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Birgit Luber

57 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Luber Germany 29 1.4k 1.3k 557 418 412 58 2.9k
Yoshinori Ino Japan 34 1.7k 1.2× 1.3k 1.0× 363 0.7× 517 1.2× 249 0.6× 63 3.5k
Johanna Lahdenranta United States 23 2.0k 1.4× 1.4k 1.1× 327 0.6× 618 1.5× 231 0.6× 51 3.6k
Jordi Barretina Spain 23 1.3k 0.9× 728 0.6× 526 0.9× 436 1.0× 238 0.6× 42 2.6k
Uma N. M. Rao United States 29 1.0k 0.7× 1.6k 1.3× 633 1.1× 434 1.0× 190 0.5× 91 3.0k
Stanley W. McCarthy Australia 35 1.6k 1.1× 2.5k 1.9× 453 0.8× 543 1.3× 644 1.6× 73 3.7k
Henning Reis Germany 33 1.1k 0.8× 891 0.7× 825 1.5× 567 1.4× 215 0.5× 182 3.1k
Danielle M. Hari United States 20 1.0k 0.7× 776 0.6× 397 0.7× 548 1.3× 182 0.4× 42 2.3k
Adriano Piris United States 27 1.8k 1.2× 2.0k 1.5× 369 0.7× 421 1.0× 307 0.7× 69 3.5k
Kris Ylaya United States 25 1.0k 0.7× 816 0.6× 362 0.6× 527 1.3× 235 0.6× 45 2.0k
Willy Landuyt Belgium 35 1.2k 0.8× 506 0.4× 510 0.9× 799 1.9× 553 1.3× 93 3.7k

Countries citing papers authored by Birgit Luber

Since Specialization
Citations

This map shows the geographic impact of Birgit Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Luber more than expected).

Fields of papers citing papers by Birgit Luber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Luber. The network helps show where Birgit Luber may publish in the future.

Co-authorship network of co-authors of Birgit Luber

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Luber. A scholar is included among the top collaborators of Birgit Luber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Luber. Birgit Luber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolbe, Katharina, Katrin Schierle, Dieter Maier, et al.. (2022). Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study. Journal of Cancer Research and Clinical Oncology. 149(3). 1319–1329. 3 indexed citations
2.
Raimúndez, Elba, Simone Keller, Sabine Hug, et al.. (2020). Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines. PLoS Computational Biology. 16(3). e1007147–e1007147. 7 indexed citations
3.
Keller, Simone, Julian Mattes, Robert Geffers, et al.. (2020). Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines. BMC Cancer. 20(1). 1039–1039. 6 indexed citations
4.
Keller, Simone, Jan Hasenauer, Dieter Maier, et al.. (2018). Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines. Molecular Oncology. 12(4). 441–462. 16 indexed citations
5.
6.
Pfarr, Nicole, et al.. (2016). Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. Journal of Cancer Research and Clinical Oncology. 143(4). 573–600. 10 indexed citations
7.
8.
Keller, Simone, Gisela Keller, Kathrin Mutze, et al.. (2012). Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines. Journal of Cancer Research and Clinical Oncology. 138(5). 843–858. 27 indexed citations
9.
Keller, Simone, Gisela Keller, Ingo Drexler, et al.. (2012). Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines. International Journal of Oncology. 41(2). 733–744. 26 indexed citations
10.
Halama, Niels, Sara Michel, Matthias Kloor, et al.. (2011). Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy. Cancer Research. 71(17). 5670–5677. 321 indexed citations
11.
Mutze, Kathrin, Rupert Langer, Karen Becker, et al.. (2010). Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer. Annals of Surgical Oncology. 17(12). 3336–3343. 61 indexed citations
12.
Luber, Birgit, et al.. (2010). Learning cellular texture features in microscopic cancer cell images for automated cell-detection. PubMed. 2010. 49–52. 11 indexed citations
13.
Hutzler, Peter, Matthias Kotzsch, Birgit Luber, et al.. (2009). Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation. Experimental Cell Research. 315(10). 1759–1771. 42 indexed citations
14.
Mateus, Ana Rita Soares, Joana Simões‐Correia, Joana Figueiredo, et al.. (2009). E-cadherin mutations and cell motility: A genotype–phenotype correlation. Experimental Cell Research. 315(8). 1393–1402. 48 indexed citations
15.
Bremm, Anja, Axel Walch, Margit Fuchs, et al.. (2008). Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations. Cancer Research. 68(3). 707–714. 62 indexed citations
16.
Aubele, Michaela, Axel Walch, Natalie Ludyga, et al.. (2008). Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. British Journal of Cancer. 99(7). 1089–1095. 44 indexed citations
17.
Gamboa‐Domínguez, Armando, Stefan Seidl, Christine Hermannstädter, et al.. (2007). Prognostic significance of p21 WAF1/CIP1 , p27 Kip1 , p53 and E-cadherin expression in gastric cancer. Journal of Clinical Pathology. 60(7). 756–761. 31 indexed citations
18.
Fuchs, Margit, Christine Hermannstädter, Katja Specht, et al.. (2004). Effect of tumor‐associated mutant E‐cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3. Journal of Cellular Physiology. 202(3). 805–813. 13 indexed citations
19.
Gamboa‐Domínguez, Armando, Yanin Chávarri-Guerra, Roberto Vargas, et al.. (2004). E-Cadherin expression in Sporadic Gastric cancer from Mexico: Exon 8 and 9 deletions are infrequent events associated with poor survival. Human Pathology. 36(1). 29–35. 31 indexed citations
20.
Fuchs, Margit, Peter Hutzler, Jürgen Schlegel, et al.. (2002). Motility Enhancement by Tumor-Derived Mutant E-Cadherin Is Sensitive to Treatment with Epidermal Growth Factor Receptor and Phosphatidylinositol 3-Kinase Inhibitors. Experimental Cell Research. 276(2). 129–141. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshinori Ino Breakdown of academic impact, for papers by Johanna Lahdenranta Breakdown of academic impact, for papers by Jordi Barretina Breakdown of academic impact, for papers by Uma N. M. Rao Breakdown of academic impact, for papers by Stanley W. McCarthy Breakdown of academic impact, for papers by Henning Reis Breakdown of academic impact, for papers by Danielle M. Hari Breakdown of academic impact, for papers by Adriano Piris Breakdown of academic impact, for papers by Kris Ylaya Breakdown of academic impact, for papers by Willy Landuyt
Rankless by CCL
2026